Press Releases

March 2, 2021

The Foundation for the National Institutes of Health (FNIH) and the National Institute on Aging (NIA), a part of the National Institutes of Health (NIH), today announced a new, second Accelerating Medicines Partnership (AMP) initiative in Alzheimer’s Disease (AMP AD). Since 2014, AMP, an innovative public-private initiative managed by the FNIH, has played a critical role in accelerating treatments for a range of diseases.

January 15, 2021

President-elect Joe Biden has asked Francis Collins, M.D., Ph.D., ex-officio member of the Foundation for the National Institutes of Health (FNIH) Board of Directors, to remain as Director of the National Institutes of Health (NIH), according to his transition team. 

September 18, 2020

The Foundation for the National Institutes of Health (FNIH) is honored to announce Anthony S. Fauci, M.D., as the recipient of the 2020 Charles A. Sanders, M.D., Partnership Award.

September 18, 2020

The Foundation for the National Institutes of Health (FNIH) today bestowed its annual Trailblazer Prize for Clinician-Scientists to Michael Wilson, M.D., of the University of California San Francisco (UCSF).

September 15, 2020

North Bethesda, MD, September 15, 2020 – The Foundation for the National Institutes of Health (FNIH) and the National Institute of Mental Health (NIMH), a part of the National Institutes of Health (NIH), announce the Accelerating Medicines Partnership in Schizophrenia (AMP SCZ), the first neuropsychiatric project of the landmark Accelerating Medicines Partnership (AMP) program managed by the FNIH.

July 23, 2020

New Program Will Advance Best Practices for Innovative Approach to Combat Malaria

July 23, 2020 – Bethesda, MD – The Foundation for the National Institutes of Health (FNIH) today announced the launch of the GeneConvene Global Collaborative, an initiative to advance the safe and responsible exploration of genetic biocontrol technologies, a set of investigational public health tools with the potential to save lives, particularly those afflicted with mosquito-borne diseases such as malaria.

June 18, 2020

North Bethesda, MD, June 18, 2020 – The Foundation for the National Institutes of Health (FNIH) has named Aviv Regev, Ph.D., winner of the 2020 Lurie Prize in Biomedical Sciences for laying the groundwork for the field of single-cell genomics and spearheading leading-edge technologies that enable a sharper perspective on human cells and applying them to revolutionize understanding of biology and disease.

June 17, 2020

New initiative encourages innovative research on devastating neurological disease

Bethesda, MD, June 17, 2020 – The National Institutes of Health plans to invest $25 million over 5 years in a new program to spur innovative research on amyotrophic lateral sclerosis (ALS), a progressive and fatal neurological disease that weakens and eventually paralyzes voluntary muscles. Accelerating Leading-edge Science in ALS (ALS²) aims to answer critical questions about this disease.

June 11, 2020

North Bethesda, MD, June 11, 2020 – The Board of Directors of the Foundation for the National Institutes of Health (FNIH) on May 21, 2020, elected as its newest member Gilbert S. Omenn, M.D., Ph.D.    

April 17, 2020

Bethesda, MD, April 17, 2020 - The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration and the European Medicines Agency to develop an international strategy for a coordinated research response to the COVID-19 pandemic.